FNIH and C-Path achieve first ever qualification of a clinical safety biomarker by FDA

(Critical Path Institute (C-Path)) The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium (BC) and the Critical Path Institute (C-Path) Predictive Safety Testing Consortium (PSTC) have received the first ever qualification of a clinical safety biomarker awarded by the US Food and Drug Administration (FDA) -- a major milestone that will improve the detection of drug-induced kidney injury in early phase drug development.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2OMIjX0